28 April 2017
News and Views
Links and Services
A study in the latest issue of the Clinical Gastroenterology & Hepatology examines the efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease.
Patients with inflammatory bowel disease (IBD) are at risk for osteoporosis and fracture.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors